Particular Aspects Related to CD4+ Level in a Group of HIV-Infected Patients and Associated Acute Coronary Syndrome

Mircea Bajdechi1,2, Adriana Gurghean1, Vlad Bataila3

  • 1Faculty of Medicine, University of Medicine and Pharmacy "Carol Davila" of Bucharest, 050474 Bucharest, Romania.

PubMed

Insights

People with HIV infection face high cardiovascular risks. Lower CD4+ T-cell counts correlated with complex coronary lesions and increased risks, but not significantly different major adverse cardiac events at one year.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Immunology

Background:

  • Individuals with HIV are prone to cardiovascular events due to chronic inflammation and atherosclerosis.
  • Certain antiretroviral therapies can also elevate cardiovascular risk.
  • Immune status, particularly CD4+ T-cell counts, is implicated in cardiovascular complications in HIV patients.

Purpose of the Study:

  • To analyze the relationship between immune status (nadir CD4+ T-cell count) and cardiovascular outcomes in HIV patients with acute coronary syndrome.
  • To assess the magnitude of coronary lesions, and thrombotic and bleeding risks in relation to immune status.

Main Methods:

  • A longitudinal, retrospective study involving 50 HIV patients with acute coronary syndrome.
  • Patients were divided into subgroups based on their nadir CD4+ T-cell count.
  • Clinical, biological, and coronary lesion parameters were assessed, along with specific risk scores.

Main Results:

  • Patients with poorer immune status (lower nadir CD4+ counts) exhibited more complex coronary lesions.
  • Increased operative and bleeding risks were observed in patients with lower CD4+ counts at one year.
  • No significant differences in major adverse cardiac and cerebrovascular events were found at 30 days and one year between subgroups.

Conclusions:

  • While lower CD4+ T-cell counts in HIV patients are associated with more complex coronary artery disease and higher operative/bleeding risks, these factors did not translate to significantly worse major adverse cardiac and cerebrovascular event rates at one year.
  • Immune status, as indicated by CD4+ nadir, is a relevant factor in assessing cardiovascular risk stratification in HIV-infected individuals.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
10
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
20
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
30
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
13
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
12
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
12